Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)

PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

October 31, 2007

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Roflumilast

Trial Locations (1)

Nycomed in Japan and Mitsubishi Tanabe Pharma Corporation, Osaka